Day trading pre-market open October 22, page-66

HYD news

“An estimated 500,000 people annually suffer from an acute coronary syndrome event in the top four Asia Pacific countries that Hydrix Medical is initially targeting.
For context, a 1% market share could translate into over $35 million in annual AngelMed Guardian revenues for Hydrix.This is now the 5th patient to receive an AngelMed Guardian implant in Singapore, with all patients recovered”